Figure 3.

EGCG decreases T cell proliferation and the Th1/Th2 ratio in the peripheral blood of rats with glaucoma. (A) Analysis of T lymphocyte proliferation by the CFSE method in the control group, model group and groups treated with EGCG for 14 and 28 days. The cells were treated with CFSE and analysed by flow cytometry. (B) The expression levels of Th1 and Th2 cytokines determined by flow cytometry in the control group, model group and groups treated with EGCG for 14 and 28 days. ^*P<0.05; ^**P<0.01; ^***P<0.001. CFSE, carboxyfluorescein diacetate succinimidyl ester; EGCG, epigallocatechin-3-gallate.